home / stock / pasg / pasg articles

PASG Articles, Passage Bio Inc.

Stock Information
Company Name: Passage Bio Inc.
Stock Symbol: PASG
Market: NASDAQ
Website: passagebio.com
Menu
PASG PASG Quote PASG Short PASG News PASG Articles PASG Message Board
Get PASG Alerts

News, Short Squeeze, Breakout and More Instantly...
Passage Bio to Present at Goldman Sachs 45th Annual Global Healthcare Conference | Benzinga

PHILADELPHIA, June 05, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ:PASG), a clinical-stage genetic medicines company focused on improving...
Passage Bio to Participate in Upcoming Investor Conferences | Benzinga

PHILADELPHIA, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ:PASG), a clinical-stage genetic medicines company focused on improving...

Passage Bio to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference | Benzinga

PHILADELPHIA, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ:PASG), a clinical-stage genetic medicines company focused on improving...

Why BlackBerry Shares Are Trading Lower By Over 5%; Here Are 20 Stocks Moving Premarket | Benzinga

Shares of BlackBerry Limited (NYSE: BB) moved lower in pre-market trading following the release of third-quarter results. BlackBerry reported qua...
Neurology-Focused Passage Bio Reveals Initial Data From Dementia Study, Outlines Strategic Priorities | Benzinga

Passage Bio Inc (NASDAQ: PASG) announced initial safety and biomarker data from three Cohort 1 patients in the ongoing global Phase 1/2 upliFT...

Passage Bio Announces Promising Initial Data From Phase 1/2 Clinical Trial of PBFT02 in FTD-GRN and Updated Strategic Priorities | Benzinga

Dose 1 of PBFT02 achieved supraphysiologic CSF progranulin levels in each of the first three treated patients at 30 days after treatment Elevated...

Monday.Com To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
Passage Bio to Present at Guggenheim's 5th Annual Inflammation, Neurology & Immunology Conference | Benzinga

PHILADELPHIA, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ:PASG), a clinical stage genetic medicines company focused on developin...

Passage Bio to Present at Chardan's 7th Annual Genetic Medicines Conference | Benzinga

PHILADELPHIA, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ:PASG), a clinical stage genetic medicines company focused on developi...

Next 10